About

Investors

Avidity Biosciences has raised $29 million in venture financing from a top-tier group of investors, including Takeda Ventures, Alethea Capital, Alexandria Real Estate Equities, Brace Pharma, EcoR1 Capital, F-Prime Capital, Moore Venture Partners, Boxer Capital of Tavistock Group and other sophisticated healthcare investors.